Thrombopoietin (TPO) is a humoral growth factor that does not induce platelet aggregation per se, but triggers platelet activation in response to several agonists. Experimentally, researchers have demonstrated that TPO may enhance platelet activation in the early stages of unstable angina (UA) and may be involved in the pathogenesis of acute coronary syndromes. More info : https://therapeutic.creativebiomart.net/cardiovascular-diseases.html